The content on this site is intended for healthcare professionals only
For the latest
cancer COVID-19 resources, click on this link
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Overcoming a newly recognised form of resistance to modern prostate cancer drugs
Study reveals racial and ethnic disparities in childhood cancers by single year of age
Antibiotic found to kill tumour cells with DNA-repair glitch
PSMA-targeted radiotracer pinpoints metastatic prostate cancer across anatomic regions
Researchers identify protein responsible for prostate cancer's aggressiveness
ASCO 2021: No survival difference for frontline combination regimens in real world intermediate-risk...
ASCO 2021: Choice of first-line platinum regimen does not significantly impact efficacy of second-li...
ASCO 2021: Post-surgery immunotherapy extends disease-free survival for select patients with kidney ...
ASCO 2021: Targeted radiotherapy offers new treatment option for patients previously treated for met...
Immunotherapy after surgery reduces deadly relapse risk in advanced bladder cancer